DURECT Corporation
US ˙ NasdaqCM ˙ US2666055007

Introduction

This page provides a comprehensive analysis of the known insider trading history of Simon X Benito. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Simon X Benito has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:INO / Inovio Pharmaceuticals, Inc. Director 12,191
US:DRRX / DURECT Corporation Director 105,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Simon X Benito. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases DRRX / DURECT Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DRRX / DURECT Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2021-12-07 DRRX BENITO SIMON X 20,000 1.0180 2,000 10.1800 20,360 1 10.5 640 3.14
2015-03-10 DRRX BENITO SIMON X 40,000 1.8065 4,000 18.0650 72,260

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DRRX / DURECT Corporation Insider Trades
Insider Sales DRRX / DURECT Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DRRX / DURECT Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DRRX / DURECT Corporation Insider Trades
Insider Purchases INO / Inovio Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DRRX / DURECT Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2015-08-14 INO BENITO SIMON X 6,000 7.2096 500 86.5152 43,258 293 136.68 25,083 57.99

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insider Sales INO / Inovio Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DRRX / DURECT Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-05-20 INO BENITO SIMON X 8,750 15.9536 729 191.4432 139,594 358 74.76 -85,094 -60.96
2018-04-12 INO BENITO SIMON X 3,750 5.2317 312 62.7804 19,619
2016-05-18 INO BENITO SIMON X 6,250 10.3710 521 124.4520 64,819

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Simon X Benito as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-21 2025-05-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,167 12,191 21.62
2024-05-16 2024-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,166 10,024 27.56
2023-05-16 2023-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 19,000 94,305 25.23
2022-07-20 2022-07-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 75,305 -2.59 2.25 -4,500 169,436
2022-07-20 2022-07-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 77,305 2.66 2.20 4,400 170,071
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 28,000 28,000
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 19,000 19,000
2022-05-17 2022-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -18,000 0 -100.00
2022-05-17 2022-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18,000 75,305 31.41
2022-03-17 2022-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 6,000 -25.00
2022-03-17 2022-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 57,305 -3.37 3.16 -6,320 181,084
2022-03-17 2022-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 59,305 3.49 2.20 4,400 130,471
2022-01-21 2022-01-19 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 8,000 -20.00
2022-01-21 2022-01-19 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 57,305 -3.37 4.27 -8,540 244,692
2022-01-21 2022-01-19 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 59,305 3.49 2.20 4,400 130,471
2021-12-09 2021-12-07 4 DRRX DURECT CORP
Common Stock
P - Purchase 20,000 105,000 23.53 1.02 20,360 106,890
2021-06-16 2021-06-15 4 DRRX DURECT CORP
Stock Option (right to buy)
A - Award 55,000 55,000
2021-05-17 2021-05-17 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,045 57,305 -5.05 6.62 -20,158 379,359
2021-05-17 2021-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,700 0 -100.00
2021-05-17 2021-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,700 60,350 16.84
2021-05-17 2021-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 18,000 18,000
2021-05-17 2021-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 27,000 27,000
2021-04-16 2021-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 0 -100.00
2021-04-16 2021-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 51,650 -3.73 8.75 -17,500 451,938
2021-04-16 2021-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 53,650 3.87 3.56 7,120 190,994
2021-03-16 2021-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 2,000 -50.00
2021-03-16 2021-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 51,650 -3.73 10.41 -20,820 537,676
2021-03-16 2021-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 53,650 3.87 3.56 7,120 190,994
2021-02-18 2021-02-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 4,000 -33.33
2021-02-18 2021-02-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 51,650 -3.73 14.68 -29,360 758,222
2021-02-18 2021-02-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 53,650 3.87 3.56 7,120 190,994
2021-01-05 2021-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,750 6,000 -31.43
2021-01-05 2021-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,750 51,650 -5.06 9.00 -24,750 464,850
2021-01-05 2021-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,750 54,400 5.32 3.56 9,790 193,664
2020-06-18 2020-06-17 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2020-05-20 2020-05-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -8,750 0 -100.00
2020-05-20 2020-05-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -8,750 51,650 -14.49 15.95 -139,594 824,003
2020-05-20 2020-05-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,750 60,400 16.94 4.60 40,250 277,840
2020-05-15 2020-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,700 8,700
2020-05-15 2020-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 13,300 13,300
2020-05-08 2020-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,013 0 -100.00
2020-05-08 2020-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,013 51,650 18.36
2019-06-20 2019-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2019-05-13 2019-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,170 0 -100.00
2019-05-13 2019-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,170 43,637 23.04
2019-05-09 2019-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,013 8,013
2019-05-09 2019-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2018-06-20 2018-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2018-05-14 2018-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -7,669 0 -100.00
2018-05-14 2018-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,669 35,467 27.59
2018-05-14 2018-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,170 8,170
2018-05-14 2018-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -3,750 0 -100.00
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,750 27,798 -11.89 5.23 -19,619 145,431
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3,750 31,548 13.49 3.56 13,350 112,311
2017-09-26 2017-09-25 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -25,000 0 -100.00
2017-09-26 2017-09-25 4 DRRX DURECT CORP
Common Stock
M - Exercise 25,000 85,000 41.67 0.82 20,495 69,683
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 16,038 71,038 29.16 1.06 17,000 75,300
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2017-05-15 2017-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -10,000 0 -100.00
2017-05-15 2017-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 27,798 56.19
2017-05-15 2017-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2017-05-15 2017-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 7,669 7,669
2016-06-23 2016-06-22 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2016-05-18 2016-05-18 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -6,250 0 -100.00 8.92 -55,750
2016-05-18 2016-05-18 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,250 17,798 -25.99 10.37 -64,819 184,583
2016-05-18 2016-05-18 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6,250 24,048 35.12 8.92 55,750 214,508
2016-05-16 2016-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 10,000 10,000 9.33 93,300 93,300
2016-05-16 2016-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 10,000 10,000
2016-05-09 2016-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -5,000 0 -100.00
2016-05-09 2016-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 17,798 39.07
2016-04-04 2016-03-31 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 14,423 14,423 1.04 15,000 15,000
2015-08-17 2015-08-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 6,000 12,798 88.26 7.21 43,258 92,268
2015-06-16 2015-06-15 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2015-05-08 2015-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 7,500 7,500 8.01 60,075 60,075
2015-05-08 2015-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 5,000 5,000
2015-03-30 2015-03-26 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 11,111 11,111
2015-03-10 2015-03-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 40,000 60,000 200.00 1.81 72,260 108,390
2014-06-17 2014-06-16 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2014-05-23 2014-05-22 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 40,000 40,000 2.20 88,000 88,000
2014-04-01 2014-03-28 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 14,423 14,423
2013-06-26 2013-06-25 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2013-05-20 2013-05-17 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 40,000 40,000 0.67 26,800 26,800
2013-02-07 2013-02-05 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 18,987 18,987
2012-08-13 2012-08-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 40,000 40,000 0.55 22,000 22,000
2012-06-21 2012-06-20 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 25,000 25,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)